D
          
        66.00
0.18 (0.27%)
| Previous Close | 65.82 | 
| Open | 66.61 | 
| Volume | 695,543 | 
| Avg. Volume (3M) | 1,450,048 | 
| Market Cap | 12,361,763,840 | 
| Price / Earnings (TTM) | 56.41 | 
| Price / Earnings (Forward) | 47.62 | 
| Price / Sales | 24.62 | 
| Price / Book | 13.15 | 
| 52 Weeks Range | |
| Earnings Date | 6 Nov 2025 | 
| Profit Margin | 39.13% | 
| Operating Margin (TTM) | 35.32% | 
| Diluted EPS (TTM) | 1.11 | 
| Quarterly Revenue Growth (YOY) | 17.10% | 
| Quarterly Earnings Growth (YOY) | 53.80% | 
| Total Debt/Equity (MRQ) | 1.15% | 
| Current Ratio (MRQ) | 6.97 | 
| Operating Cash Flow (TTM) | 273.26 M | 
| Levered Free Cash Flow (TTM) | 216.76 M | 
| Return on Assets (TTM) | 12.31% | 
| Return on Equity (TTM) | 22.50% | 
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bullish | Mixed | 
| Health Information Services (Global) | Bullish | Mixed | |
| Stock | Doximity, Inc. | Bullish | Bullish | 
AIStockmoo Score
              0.5
            
                      | Analyst Consensus | 1.5 | 
| Insider Activity | NA | 
| Price Volatility | 1.0 | 
| Technical Moving Averages | 0.0 | 
| Technical Oscillators | -0.5 | 
| Average | 0.50 | 
| 
               Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.  | 
          |
| Sector | Healthcare | 
| Industry | Health Information Services | 
| Investment Style | Small Growth | 
| % Held by Insiders | 2.24% | 
| % Held by Institutions | 93.70% | 
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 85.00 (B of A Securities, 28.79%) | Buy | 
| Median | 75.00 (13.64%) | |
| Low | 62.00 (JP Morgan, -6.06%) | Sell | 
| Average | 73.00 (10.61%) | |
| Total | 7 Buy, 2 Hold, 2 Sell | |
| Avg. Price @ Call | 68.84 | |
| Firm | Date | Target Price | Call | Price @ Call | 
|---|---|---|---|---|
| B of A Securities | 27 Oct 2025 | 85.00 (28.79%) | Buy | 68.50 | 
| JP Morgan | 10 Oct 2025 | 62.00 (-6.06%) | Sell | 65.61 | 
| Evercore ISI Group | 08 Oct 2025 | 81.00 (22.73%) | Buy | 73.53 | 
| Keybanc | 08 Oct 2025 | 80.00 (21.21%) | Buy | 73.53 | 
| Goldman Sachs | 01 Oct 2025 | 64.00 (-3.03%) | Sell | 70.64 | 
| Canaccord Genuity | 18 Sep 2025 | 67.00 (1.52%) | Hold | 73.60 | 
| 08 Aug 2025 | 59.00 (-10.61%) | Hold | 66.58 | |
| Baird | 11 Sep 2025 | 80.00 (21.21%) | Buy | 70.26 | 
| Piper Sandler | 11 Aug 2025 | 69.00 (4.55%) | Buy | 61.83 | 
| Needham | 08 Aug 2025 | 75.00 (13.64%) | Buy | 66.58 | 
| Raymond James | 08 Aug 2025 | 75.00 (13.64%) | Buy | 66.58 | 
| Wells Fargo | 08 Aug 2025 | 65.00 (-1.52%) | Hold | 66.58 | 
| 04 Aug 2025 | 62.00 (-6.06%) | Hold | 58.30 | |
| Show more | ||||
No data within this time range.
| Date | Type | Details | 
|---|---|---|
| 16 Oct 2025 | Announcement | Doximity to Release Fiscal 2026 Second Quarter Results on November 6, 2025 | 
| 07 Aug 2025 | Announcement | Doximity Acquires Pathway, a Leader in AI Clinical Reference | 
| 07 Aug 2025 | Announcement | Doximity Announces Fiscal 2026 First Quarter Financial Results | 
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - | 
| Unrealized Profit | - | 
| Dividend Received 2025 | - | 
| Total Profit | - | 
| Avg. Return | - | 
| Quantity (Buy) | - | 
| Avg. Price (Buy) | - | 
| Quantity (Sold) | - | 
| Avg. Price (Sold) | - |